Skip to main content

Vodafone assigns PR mandate to Adfactors PR


Vodafone India has appointed Adfactors Public Relations to handle its public relations activity in India with effect from August 1, 2012.
Commenting on the development, Suresh Rangarajan, Head – Corporate Communications, Vodafone India informed, “Adfactors PR was selected after a rigorous two-month long evaluation process by Vodafone India, which involved presentations from five shortlisted PR agencies. The evaluation was done by a cross functional team at Vodafone India.”
On selecting Adfactors, Rangarajan said, “After two rounds of evaluation at different levels, on four parameters – understanding of business needs, proposed solution, capacity/ capability of the agency and presentation, Adfactors PR emerged as a unanimous choice.”
The servicing team at Adfactors Public Relations will be led by Atul Takle, Senior Vice President, Adfactors PR. Commenting on the new assignment he said that the PR service will cover multiple circles, involve mainstream activities as well as initiatives at a local level. Strategies would be devised keeping the communication requirements in mind, Takle added.
Founded in 1997, Adfactors PR is India's leading PR consultancy with over 250 large and mid-sized Clients on a retainer basis and several hundred projects.  In the Holmes List 2010-11, Adfactors PR is the first and only Indian and independent PR consultancy amongst the Top 10 Asian PR consultancies and ranked amongst the Top 100 in the world...

Comments

Popular posts from this blog

Smallcase Platform: 2025 Wealth Creation Strategies to Achieve Your Investment Goals

  By Dr. Vikas Gupta, CEO and Chief Investment Strategist, OmniScience Capital In the intricate world of finance, wealth creation is a universal aspiration among investors, though few truly attain it. With a plethora of investment products, philosophies, and strategies available, the challenge is identifying an approach that not only offers returns but also minimizes risk. At OmniScience Capital, we believe the key to successful wealth creation lies in a scientific and disciplined investment strategy. Our unique offerings, rooted in the principles of Scientific Investing, are designed to help you achieve your financial goals with confidence. Pioneering Global Investing and Outperforming on Smallcase Platform OmniScience Capital, a global investment management firm specializing in global and Indian equities, is a pioneer in global investing and growth vectors such as Defense and Digital Transformation. Our strategies have consistently identified and capitalized on growth vectors tha...

Country Delight Launches NMR-Tested Honey: The Gold Standard of Purity

  Country Delight continues strengthening its promise of delivering the best purity and quality by launching 100% Pure Farm Honey (NMR Tested) Country Delight, a trusted name in premium and natural essentials, has announced the launch of 100% Pure Farm Honey (NMR Tested). Country Delight’s Farm Honey is Nuclear Magnetic Resonance (NMR) tested by a certified lab in Germany, making it one of the most authentic and reliable kitchen ingredients available to Indian homes. It also undergoes rigorous testing on 36 quality parameters as per FSSAI standards, including physicochemical, antibiotic and microbial, to rule out the presence of added sugars. Honey is not just a natural sweetener; it is increasingly valued for its functional benefits. With Country Delight's NMR-tested honey, consumers can enjoy a product that supports wellness through its natural composition, which is rich in antioxidants and phytonutrients and offers advantages over refined sugars.  Adulteration with cheaper ...

Prachay Capital’s Public Issue of Secured NCDs Fully Subscribed at 113.36%

Prachay Capital Limited, an RBI-registered Non-Banking Financial Company – Investment and Credit Company (NBFC-ICC), has successfully closed its public issue of Secured, Rated, Redeemable Non-Convertible Debentures (NCDs) at 113.36% subscription, according to exchange data. The issue, which opened on February 28, 2025, on the Bombay Stock Exchange (BSE), aimed to raise Rs 50 crore (excluding the greenshoe option) and closed on March 13, 2025. With a BSE listing, this issue was open for subscription to retail investors, high-net-worth individuals (HNIs), institutional investors, and corporates. The maiden NCDs issue is scheduled to list on 24 March 2025.  Rated BBB-/Stable by CRISIL, these NCDs offer investors a 13% per annum return with monthly interest payouts, making them an attractive fixed-income opportunity. The proceeds will be deployed as per the company’s stated fund allocation plan. Fund Utilization: Minimum 75% for the purpose of onward lending, investments in current and...